{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:04:47Z","timestamp":1793217887367,"version":"4.5.0"},"reference-count":58,"publisher":"National Academy of Sciences","issue":"36","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI15614"],"award-info":[{"award-number":["AI15614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010279","name":"Interleukin Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100010279","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL106582"],"award-info":[{"award-number":["HL106582"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL121776"],"award-info":[{"award-number":["HL121776"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2022,9,6]]},"abstract":"<jats:p>Calcific aortic valve disease (CAVD) is common in people over the age of 65. Progressive valvular calcification is a characteristic of CAVD and due to chronic inflammation in aortic valve interstitial cells (AVICs) resulting in CAVD progression. IL-38 is a naturally occurring anti-inflammatory cytokine; here, we report lower levels of endogenous IL-38 in AVICs isolated from patients\u2019 CAVD valves compared to AVICs from non-CAVD valves. Recombinant IL-38 suppressed spontaneous inflammatory activity and calcium deposition in cultured AVICs. In mice, knockdown of IL-38 enhanced the production of inflammatory mediators in murine AVICs exposed to the proinflammatory stimulant matrilin-2. We also observed that in cultured AVICs matrilin-2 stimulation activated the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome with procaspase-1 cleavage into active caspase-1. The addition of IL-38 to matrilin-2\u2013treated AVICs suppressed caspase-1 activation and reduced the expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, runt-related transcription factor 2, and alkaline phosphatase. Aged IL-38\u2013deficient mice fed a high-fat diet exhibited aortic valve lesions compared to aged wild-type mice fed the same diet. The interleukin-1 receptor 9 (IL-1R9) is the putative receptor mediating the anti-inflammatory properties of IL-38; we observed that IL-1R9\u2013deficient mice exhibited spontaneous aortic valve thickening and greater calcium deposition in AVICs compared to wild-type mice. These data demonstrate that IL-38 suppresses spontaneous and stimulated osteogenic activity in aortic valve via inhibition of the NLRP3 inflammasome and caspase-1. The findings of this study suggest that IL-38 has therapeutic potential for prevention of CAVD progression.<\/jats:p>","DOI":"10.1073\/pnas.2202577119","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T15:13:40Z","timestamp":1661786020000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":40,"title":["Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3"],"prefix":"10.1073","volume":"119","author":[{"given":"Erlinda","family":"The","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-7159","authenticated-orcid":false,"given":"Dennis M.","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado Denver, Aurora, CO 80045"},{"name":"Department of Internal Medicine and Radboud Institute of Molecular Life Science, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhou","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Ao","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fullerton","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-8316","authenticated-orcid":false,"given":"Charles A.","family":"Dinarello","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhong","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado Denver, Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.043391"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000157"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165620"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx141"},{"key":"e_1_3_4_5_2","first-page":"163","article-title":"Advanced age and the clinical outcomes of transcatheter aortic valve implantation","volume":"11","author":"Alsara O.","year":"2014","unstructured":"O. Alsara, A. Alsarah, H. Laird-Fick, Advanced age and the clinical outcomes of transcatheter aortic valve implantation. J. Geriatr. Cardiol. 11, 163\u2013170 (2014).","journal-title":"J. Geriatr. Cardiol."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2015.10.2.108"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-012-9579-6"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/364310"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-316493"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2005.01.002"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-016-9726-9"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.971028"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070251"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309021"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.14.9268"},{"key":"e_1_3_4_16_2","first-page":"986127","article-title":"Matrilin-2 is a widely distributed extracellular matrix protein and a potential biomarker in the early stage of osteoarthritis in articular cartilage","volume":"2014","author":"Zhang S.","year":"2014","unstructured":"S. Zhang , Matrilin-2 is a widely distributed extracellular matrix protein and a potential biomarker in the early stage of osteoarthritis in articular cartilage. BioMed Res. Int. 2014, 986127 (2014).","journal-title":"BioMed Res. Int."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71385"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1369\/0022155417740880"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020385"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01566-2"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01462"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010095200"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948390"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2018.01.001"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1143-3"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15737"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjw006"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619667114"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00201"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300116"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00433-4"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1944"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000493029"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/946509"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010076"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-014-1229-z"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.06.024"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000000487"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328"},{"key":"e_1_3_4_40_2","first-page":"4063562","article-title":"NLRP3 inflammasome and inflammatory diseases","volume":"2020","author":"Wang Z.","year":"2020","unstructured":"Z. Wang , NLRP3 inflammasome and inflammatory diseases. Oxid. Med. Cell. Longev. 2020, 4063562 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2020.03.016"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00564-2015"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14704"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6370911"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840719"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004462"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.97"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500648"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066254"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403434200"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.4161\/cib.3.3.11414"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.04.141"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00829"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3103"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072646"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248668"},{"key":"e_1_3_4_58_2","first-page":"1","article-title":"Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in\u00a0vitro by inhibiting NLRP3 Inflammasome activation","volume":"21","author":"Huang Y.","year":"2021","unstructured":"Y. Huang , Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in\u00a0vitro by inhibiting NLRP3 Inflammasome activation. BMC Anesthesiol. 21, 1\u201312 (2021). Correction in: BMC Anesthesiol. 21, 141 (2021).","journal-title":"BMC Anesthesiol."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2202577119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T15:17:56Z","timestamp":1661786276000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2202577119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":58,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022,9,6]]}},"alternative-id":["10.1073\/pnas.2202577119"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2202577119","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"2022-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2202577119"}}